Oseltamivir Phosphate
Product Images NDC 67296-1725

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 67296-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A1279325 8446 412f 83b1 46ed6c5666c0 01)

FDA Label Image

Principal Display Panel (Carton-30)

This extract is a description for Oseltamivir Phosphate Capsules, USP. It provides details such as the NDC code, dosage information, storage instructions, manufacturing and distribution details, and other important prescribing information. The capsules are presented in unit-dose blister packs, containing 30mg of Oseltamivir Phosphate each. This medication is used for flu treatment and prevention.*

FDA Label Image

Principal Display Panel (Carton-45mg)

This is information on Oseltamivir Phosphate capsules, USP, with each capsule containing Oseltamivir Phosphate equivalent to 45 mg Oselamivir free base. The packaging contains 10 capsules (1x10 unit-dose). It provides important prescription details and usage dosages. It should be stored at 20° to 25° C (68° to 77° F), with excursions permitted between 15° to 30°C (59° to 86°F). The product is manufactured by Strides Pharma Science Limited in Bengaluru, India, and distributed by Strides Pharma Inc. in East Brunswick, NJ.*

FDA Label Image

Principal Display Panel (Carton-75mg)

This is a description for Oseltamivir Phosphate Capsules, USP 75 mg. Each capsule contains Oseltamivir Phosphate equivalent to 75 mg Oseltamivir. The medication is available in 10 (1x10 unit-dose) capsules packaging. It is important to follow dosage recommendations and prescribing information provided in the accompanying insert. Store between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The product is distributed by Strides Pharma Inc. and has the code No.: KR/DRUGS/KTK/25/415/98.*

FDA Label Image

Principal Display Panel (30 mg foil)

FDA Label Image

Principal Display Panel (45 mg foil)

FDA Label Image

Principal Display Panel (75 mg foil)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.